GGrantIndex
← Leaderboards

David S Weiss

Univ Of North Carolina Chapel Hill

$16,596,967
Attributed
$16,596,967
Total exposure
13
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.2M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,471,413 · 12
VA$0 · 2

By mechanism

U19$14,716,375 · 5
R01$8,411,293 · 3
U54$1,860,521 · 1
R33$1,569,981 · 1
R21$473,243 · 1
R56$440,000 · 1

Top collaborators

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Bacteria

Research focus

BacteriaNovel TherapeuticsInfectionIn VivoAntibiotic ResistanceCessation Of LifeCellsResistanceAntibioticsCombatDesignLifeInsightIntermediate ResistancePathogenMolecularPharmaceutical PreparationsGeneticBacterial ResistanceMedicalClinicMortalityBacterial InfectionsModern Medicine

Grant awards (47)

Heteroresistance Interdisciplinary Research Unit$2,110,756
U19 · FY2025 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Admin Core)$351,793
U19 · FY2025 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Project 2)$351,792
U19 · FY2025 · AI · contact PI
Novel Antibiotic Susceptibility Testing Platform for Detecting Resistant Subpopulations$0
I01 · FY2025 · VA · contact PI
Heteroresistance Interdisciplinary Research Unit$2,184,767
U19 · FY2024 · AI · contact PI
Exploitation of multiple heteroresistance for effective antibiotic combination therapy$794,789
R01 · FY2024 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Project 2)$678,395
U19 · FY2024 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Admin Core)$120,972
U19 · FY2024 · AI · contact PI
Novel Antibiotic Susceptibility Testing Platform for Detecting Resistant Subpopulations$0
I01 · FY2024 · VA · contact PI
Heteroresistance Interdisciplinary Research Unit$2,255,690
U19 · FY2023 · AI · contact PI
Exploitation of multiple heteroresistance for effective antibiotic combination therapy$803,714
R01 · FY2023 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Project 2)$550,933
U19 · FY2023 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Admin Core)$306,617
U19 · FY2023 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit$2,150,960
U19 · FY2022 · AI · contact PI
Exploitation of multiple heteroresistance for effective antibiotic combination therapy$803,714
R01 · FY2022 · AI · contact PI
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria$433,628
R01 · FY2022 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Project 2)$358,493
U19 · FY2022 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Admin Core)$358,493
U19 · FY2022 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit$2,172,273
U19 · FY2021 · AI · contact PI
Exploitation of multiple heteroresistance for effective antibiotic combination therapy$803,714
R01 · FY2021 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Project 2)$564,570
U19 · FY2021 · AI · contact PI
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria$434,697
R01 · FY2021 · AI · contact PI
Heteroresistance Interdisciplinary Research Unit (Admin Core)$199,871
U19 · FY2021 · AI · contact PI
Exploitation of multiple heteroresistance for effective antibiotic combination therapy$823,339
R01 · FY2020 · AI · contact PI
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria$435,819
R01 · FY2020 · AI · contact PI
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria$436,767
R01 · FY2019 · AI · contact PI
Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii$0
I01 · FY2019 · VA · contact PI
CRISPR/Cas systems in bacterial gene regulation and virulence$439,591
R01 · FY2018 · AI · contact PI
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria$437,629
R01 · FY2018 · AI · contact PI
Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii$0
I01 · FY2018 · VA · contact PI
CRISPR/Cas systems in bacterial gene regulation and virulence$440,196
R01 · FY2017 · AI · contact PI
Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii$0
I01 · FY2017 · VA · contact PI
ArmR: a novel drug target and mediator of antibiotic resistance$523,188
R33 · FY2016 · AI · contact PI
CRISPR/Cas systems in bacterial gene regulation and virulence$440,747
R01 · FY2016 · AI · contact PI
Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii$0
I01 · FY2016 · VA · contact PI
ArmR: a novel drug target and mediator of antibiotic resistance$523,329
R33 · FY2015 · AI · contact PI
CRISPR/Cas systems in bacterial gene regulation and virulence$441,247
R01 · FY2015 · AI · contact PI
ArmR: a novel drug target and mediator of antibiotic resistance$523,464
R33 · FY2014 · AI · contact PI
CRISPR/Cas systems in bacterial gene regulation and virulence$441,702
R01 · FY2014 · AI · contact PI
Molecular Characterization of Francisella tularensis SchuS4 virulence factors$448,781
U54 · FY2013 · AI · contact PI
ArmR: a novel drug target and mediator of antibiotic resistance$257,518
R21 · FY2013 · AI · contact PI
Molecular Characterization of Francisella tularensis SchuS4 virulence factors$390,943
U54 · FY2012 · AI · contact PI
ArmR: a novel drug target and mediator of antibiotic resistance$215,725
R21 · FY2012 · AI · contact PI
Modulation of host defenses by the bacterial pathogen Francisella tularensis$440,000
R56 · FY2011 · AI · contact PI
Molecular Characterization of Francisella tularensis SchuS4 virulence factors$383,636
U54 · FY2011 · AI · contact PI
Molecular Characterization of Francisella tularensis SchuS4 virulence factors$453,299
U54 · FY2010 · AI · contact PI
Molecular Characterization of Francisella tularensis SchuS4 virulence factors$183,862
U54 · FY2009 · AI · contact PI